Inhibition of dopamine receptor <scp>D1</scp> signaling promotes human bile duct cancer progression via <scp>WNT</scp> signaling-Reference-Cited by-同舟云学术

Inhibition of dopamine receptor D1 signaling promotes human bile duct cancer progression via WNT signaling

Published:2022-12-14 Issue:4 Volume:114 Page:1324-1336
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Yogo Akitada¹²^ORCID,Masui Toshihiko²^ORCID,Takaishi Shigeo¹³^ORCID,Masuo Kenji¹³,Chen Ru¹³,Kasai Yosuke²,Nagai Kazuyuki²,Anazawa Takayuki²,Watanabe Sadanori¹⁴,Sakamoto Satoko⁵,Watanabe Akira⁵,Inagaki Ryosaku¹⁴,Nakagawa Masahiro M.¹⁶,Ogawa Seishi¹⁶,Seno Hiroshi¹³,Uemoto Shinji²⁷,Hatano Etsuro²

Affiliation:

1. DSK Project, Medical Innovation Center, Graduate School of Medicine Kyoto University Kyoto Japan

2. Division of Hepato‐Biliary‐Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine Kyoto University Kyoto Japan

3. Department of Gastroenterology and Hepatology, Graduate School of Medicine Kyoto University Kyoto Japan

4. Cancer Research Unit Sumitomo Pharma Co., Ltd Osaka Japan

5. Medical Innovation Center Kyoto University Graduate School of Medicine Kyoto Japan

6. Department of Pathology and Tumor Biology Kyoto University Kyoto Japan

7. Shiga University of Medical Science Shiga Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Dainippon Sumitomo Pharma

Publisher